Abstract
To study the functional roles of dopamine receptors, we decided to raise antibodies against these proteins. To make antigen, we expressed the whole 3rd cytoplasmic loop of dopamine receptors in a fusion protein with glutathione-S-transferase (GST). For D2 and D3 receptors, it was successful to express and purify fusion proteins for the whole 3rd cytoplasmic loops. However, we could not express the fusion protein for the whole 3rd cytoplasmic loopsof D4 dopamine receptor in the bacteria. To study the causes that prevent the bacterial expression of the GST-fusion protein of the 3rd cytoplasmic loop of D4 dopamine receptor, we conducted more detailed studies on D4 dopamine receptor. To locate the region which prevents bacterial expression, we made sequential constructs in the 3rd cytoplasmic loop decreasing the size step by step, and confirmed their expressions in the SDS PAGE. It was found that certain regions of 3rd cytoplasmic loop of D4 dopamine receptor, located in N-terminal side of the 3rd cytoplasmic loop of D4 dopamine receptor suppress the bacterial expression of fusion protein.
Similar content being viewed by others
References Cited
Brown, J. H. and Markman, M. H., Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine 3′∶5′-cyclic monophosphate formation in intact retina.Proc. Natl. Acad. Sci. USA, 69, 539–543 (1972).
Bunzow, J. R., Van Tol, H. H. M., Grandy, D. K., Albert, P., Salon, J., Christie, M., Machida, C., Neve, K. A. and Civelli, O., Cloning and expression of a rat D2 dopamine receptor cDNA.Nature, 336, 783–788 (1988).
Dearry, A., Gingrich, J. A., Falardeau, P., Fremeau, R. T., Jr., Bates, M. D. and Caron, M. G., Molecular cloning and expression of the gene for a human D1 dopamine receptor.Nature, 347, 72–76 (1990).
Defrance, J. F., Sikes, R. W. and Chronister, R. B., Dopamine action in the nucleus accumbens.J. Neurophysiol., 54, 1568–1577 (1985).
Durcan, M. J., Rigdon, G. C., Norman, M. H. and Morgan, P. F., Is clozapine selective for the dopamine D4 receptor?Life Sci., 57, PL275–83 (1995).
Hornykiewicz, O., Die topische Lokalisation und das Verhalten von Noradrenalin und Dopamine (3-Hydroxytyramine) in der Substantia nigra des normalen und Parkinson-kranken Menschen.Wien. Klin. Wochenschr., 75, 309–312 (1963).
Kane, J. M., Honigfield, G., Singer, J. and Meltzer, H., Clozapine in treatment-resistant schizophrenics.Psychopharmacol. Bull., 24, 67–69 (1988).
Kebabian, J. W. and Calne, D. B., Multiple receptors for dopamine.Nature, 227, 93–96 (1979).
Kim, A-Y, Lee, S-Y and Kim, K-M, Preparation of δ-opioid receptor-specific antibodies using molecular cloned genes.Arch. Pharm. Res., 18, 113–117 (1995).
Matthysse, S., Nucleus accumbens and schizophrenia, In Chronister, R. B. and Defranace, J. F. (Eds.),The neurobiology of nucleus accumbens, Hear Institute, Brunswick, ME., 1981, pp. 351–357.
O'Malley, K. L., Harmon, S., Tang, L. and Todd, R. D., The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system.The New Biologist, 4, 137–146 (1992).
Smith, D. B. and Johnson, K. S., Single step purification of polypeptide expressed inEscherichia coli as fusions with glutathione-S-transferase.Gene, 67, 31–40 (1988).
Snyder, S. H., Amphetamine psychosis: a “model” schizophrenia mediated by catecholamines.Am J. Psychiatry, 130, 61–67 (1973).
Sokoloff, P., Giros, B., Martres, M., Bouthenet, M. and Schwartz, J., Molecular cloning and characterization of a novel dopamine receptor (D3) as target for neuroleptics.Nature, 347, 146–151 (1990).
Stevens, J. R., Schizophrenia and dopamine regulation in the mesolimbic system.Trends in Neurosci., 2, 102–105 (1979).
Sunahara, R. K., Niznik, H. B., Weiner, D. M., Stormann, T. M., Brann, M. R., Kennedy, J. L., Gelernter, J. E., Razmahell, R., Yang, Y., Israel, Y., Seeman, P. and O'Dowd, B. F., Human dopamine D1 receptor encoded by an intronless gene on chromosome 5.Nature, 347, 80–83 (1990).
Sunahara, R. K., Guan, H., O'Dwod, B. F., Seeman, P., Laurier, L. G., Ng, G., George, S. R., Torchia, J., Van Tol, H. H. M. and Niznik, H. B., Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.Nature, 350, 614–619 (1991).
Van Tol, H. H. M., Bunzow, J. R., Guan, H., Sunahara, R. K., Seeman, P., Niznik, H. B. and Civelli, O., Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine.Nature, 350, 610–614, (1991).
Wise, R. A., The role of reward pathways in the development of drug dependence.Pharmac. Ther., 35, 227–263 (1987).
Zhou, Q., Grandy, D. K., Thambi, L., Kushner, J. A., Van Tol, H. H. M., Cone, R., Pribnow, D., Salon, J., Bunzow, J. R. and Civelli, O., Cloning and expression of human and rat D1 dopamine receptors.Nature, 347, 76–80 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cheong, JS., Kim, AY. & Kim, KM. Identification of certain sequences in the 3rd cytoplasmic loop of D4 dopamine receptor that suppress the bacterial expression. Arch. Pharm. Res. 19, 275–279 (1996). https://doi.org/10.1007/BF02976240
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02976240